Medicaid Policy and Liver Transplant for Alcohol-Associated Liver Disease

被引:15
|
作者
Lee, Brian P. [1 ]
Vittinghoff, Eric [2 ]
Pletcher, Mark J. [2 ]
Dodge, Jennifer L. [2 ]
Terrault, Norah A. [3 ]
机构
[1] Univ Calif San Francisco, Dept Gastroenterol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
[3] Univ Southern Calif, Div Gastrointestinal & Liver Dis, 1450 San Pablo Ave,HC4 Room 3054, Los Angeles, CA 90033 USA
关键词
D O I
10.1002/hep.31027
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims In some states, liver transplantation (LT) for alcohol-associated liver disease (ALD) is covered by Medicaid only with documentation of abstinence and/or alcohol rehabilitation. Different Medicaid policies may affect the distribution of LT for ALD, particularly post-2011, as centers have adopted early (i.e., specific abstinence period not required) LT practices. Approach and Results We surveyed Medicaid policies in all states actively performing LT and linked state policies to prospectively collected national registry data on LT recipients from 2002 to 2017 with ALD as the primary listing diagnosis. We categorized Medicaid policies for states as "restrictive" (requiring documentation of a specific abstinence period and/or rehabilitation) versus "unrestrictive" (deferring to center eligibility policies). Difference-of-differences analysis, comparing 2002-2011 versus 2012-2017, evaluated whether restrictive policies were associated with decreased proportion of LTs paid by Medicaid among patients with ALD post-2011. We performed sensitivity analyses to account for any differences by diagnosis of hepatocellular carcinoma, hepatitis C virus, nonalcoholic steatohepatitis, or Medicare insurance. We also performed a sensitivity analysis to account for any difference by prevalence of ALD among restrictive versus unrestrictive states. Of 10,836 LT recipients in 2002-2017, 7,091 were from 24 states in the restrictive group and 3,745 from 14 states in the unrestrictive group. The adjusted proportion (95% confidence interval) of LTs paid by Medicaid among restrictive versus unrestrictive states between 2002 and 2011 was 17.6% (15.4%-19.8%) versus 18.9% (15.4%-22.3%) (P = 0.54) and between 2012 and 2017, 17.2% (14.7%-19.7%) versus 23.2% (19.8%-26.6%) (P = 0.005). In difference-of-differences analysis, restrictive (versus unrestrictive) policies were associated with a 4.7% (0.8%-8.6%) (P = 0.02) absolute lower adjusted proportion of LTs for ALD paid by Medicaid post-2011. Conclusions Restrictive Medicaid policies are present in most states with active LT centers and are associated with lower proportions of LTs for ALD paid by Medicaid post-2011 compared to states with unrestrictive Medicaid policies. Reevaluation of Medicaid alcohol use policies may be warranted, to align more closely with contemporary center-level practices.
引用
收藏
页码:130 / 139
页数:10
相关论文
共 50 条
  • [1] Liver Transplant for Alcohol-Associated Liver Disease
    Zhang, Bo-Han
    Cai, Yun-Shi
    Yang, Jia-Yin
    JAMA SURGERY, 2022, 157 (04) : 360 - 360
  • [2] Outcomes following liver transplant for alcohol-associated liver disease: comparing alcohol-associated hepatitis and cirrhosis
    Schroeder, Matthew
    Pedersen, Mark
    Petrasek, Jan
    Grant, Lafaine
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (05)
  • [3] Transplant Center Attitudes Toward Early Liver Transplant for Alcohol-associated Liver Disease
    Mitchell, Jonathan
    Herrick-Reynolds, Kayleigh
    Motter, Jennifer D.
    Teles, Mayan
    Kates, Olivia
    Sung, Hannah
    Chen, Po-Hung
    King, Elizabeth
    Cameron, Andrew
    TRANSPLANTATION DIRECT, 2023, 9 (09): : E1532
  • [4] Alcohol-Associated Liver Disease
    Jophlin, Loretta L.
    Singal, Ashwani K.
    Shah, Vijay H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (03): : 495 - 499
  • [5] Alcohol-associated liver disease
    Mackowiak, Bryan
    Fu, Yaojie
    Maccioni, Luca
    Gao, Bin
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (03):
  • [6] Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease
    Herrick-Reynolds, Kayleigh M.
    Punchhi, Gopika
    Greenberg, Ross S.
    Strauss, Alexandra T.
    Boyarsky, Brian J.
    Weeks-Groh, Sharon R.
    Krach, Michelle R.
    Anders, Robert A.
    Gurakar, Ahmet
    Chen, Po-Hung
    Segev, Dorry L.
    King, Elizabeth A.
    Philosophe, Benjamin
    Ottman, Shane E.
    Wesson, Russell N.
    Garonzik-Wang, Jacqueline M.
    Cameron, Andrew M.
    JAMA SURGERY, 2021, 156 (11) : 1026 - 1034
  • [7] Liver transplantation for Alcohol-associated liver disease
    Simonetto, Douglas A.
    Winder, G. Scott
    Connor, Ashton A.
    Terrault, Norah A.
    HEPATOLOGY, 2024, 80 (06) : 1441 - 1461
  • [8] The Experience of the Alcohol-Associated Liver Disease Organ Transplant Recipient Following Liver Transplantation
    Greenberg, Cindy
    Roush, Karen
    NURSING RESEARCH, 2024, 73 (03) : E117 - E117
  • [9] Transplant Center Attitudes Towards Early Liver Transplantation for Alcohol-associated Liver Disease
    Mitchell, Jonathan
    Motter, Jennifer
    Teles, Mayan
    Herrick-Reynolds, Kayleigh
    Sung, Hannah
    Chen, Po-Hung
    King, Elizabeth
    Cameron, Andrew
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (01) : S58 - S58
  • [10] Pathogenesis of Alcohol-Associated Liver Disease
    Mandrekar, Pranoti
    Mandal, Abhishek
    CLINICS IN LIVER DISEASE, 2024, 28 (04) : 647 - 661